when were glp 1 agonists discovered Evolution of GLP-1 receptor (1906-2025): From discovery to The GLP-1 journey: from discovery
Description
Not for use in patients with type 1 diabetes or diabetic ketoacidosis
Depending on your preference, the prescription can be sent directly to your pharmacy or, in some cases, delivered right to your home
Zepbound and Mounjaro are dual-agonist drugs and activate two receptors in the brain and throughout the body: GLP-1 and glucose-dependent insulinotropic polypeptide or GIP
Journal of Diabetes 10353356
Association between bariatric surgery and long-term survival
But that changed with the approval and launch of the Wegovy pill in December 2025 and then again with the launch of Foundayo in April 2026
